Cancer Clinical Trial
Official title:
Assessment of Patient Satisfaction in Palliative Cancer When They Return Home After Hospitalization in Palliative Care
Verified date | March 2016 |
Source | Centre Francois Baclesse |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The proposed work is part of a multidisciplinary approach to continuity of care in the
particular context of the palliative phase of cancer. In conducting this study, we would
like to characterize, at the regional level, satisfaction with the care of patients and
their families in their care home situations palliative cancer. This evaluation will be
based on questionnaires adapted versions in French language satisfaction questionnaires
recently validated for patients in palliative situation and supported home care.
It will also identify the challenges faced by both patients, caregivers attending
physicians.
The evaluation of these elements is a prerequisite to propose ways of improving at a
hospital palliative care for output relay and anticipate the coordination of care for
optimal care of the patient at home, to meet the expectations of different stakeholders, or
even prevent certain readmissions "avoidable".
Status | Terminated |
Enrollment | 4 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient (s) age (s) of 18 or more; - Patient (s) reached (s) from cancer wholly palliative phase (estimated life expectancy of less than 3 months) in the judgment of the investigator; - Patient (s) hospital (s) in palliative care and candidate for a return home; - Patient (s) able to communicate with the investigator or his representative; - Patient (s) have received clear information on the diagnosis and prognosis of their disease; - Free and informed consent signed. Exclusion Criteria: - Patient (s) under guardianship or unable to give informed consent; - Patient (s) whose cognitive functions can not be questioned. - Patient (s) whose psychological distress does not participate in the study |
Country | Name | City | State |
---|---|---|---|
France | Centre François Baclesse | Caen |
Lead Sponsor | Collaborator |
---|---|
Centre Francois Baclesse |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Patient quality of life | Evaluation of the quality of life of patients at home over time. | Patient quality of life will be evaluated at day 15, months 1 to 6 | |
Other | The type and intensity of symptoms | Characterize the type and intensity of symptoms, physical and mental, and supported over time; | The type and intensity of symptoms will be evaluated on day 15, months1 to 6 | |
Primary | Patient care satisfaction | Evaluation of satisfaction with the care of patients in palliative phase of cancer 15 days after their home return after hospitalization in palliative care. | 15 days after their home return | |
Secondary | Satisfaction of the primary caregiver | Evaluation of the satisfaction of the primary caregiver of maintaining the home of his relatives with cancer in palliative phase | Satisfaction of the primary caregiver will be evaluated at day 15, months 1 to 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|